Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #16
    Hey, thanks for figuring out that it was CCGG . I thought it might be something like that. It must be that a certain distance into the read if the CCGG happens it starts stuttering. I see that it is quality "masked" but that the "bad quality mask" is short by about 2-3 bps. The bad call is often in that "good quality" area, in the data I look at. The "snp call must have enough evidence in both directions" rule should save the day.

    Comment

    • Michael.James.Clark
      Senior Member
      • Apr 2009
      • 207

      #17
      Originally posted by fpepin View Post
      I also talked to more people about this issue and the answer is that this is a well-known issue when you have a specific tetramer (CCGG, if I remember correctly) that ends up causing bases to be skipped.

      This explains why the differences are strand specific and why it happens in very specific places in the genome (including in completely different labs). The reads generally end up being clipped soon after because the indel, but there are cases that are repetitive enough that the few other bases match by chance, leading for the trimming to occur later and the read to be kept.

      I'm not quite sure where would be best place to recognize this corner case and deal with it, but in my case I'll take the lazy way out and just filter them out at the end.

      Thanks for all who offered suggestions.
      Ah yes! I recall a thread discussing that very issue here a while back now that you mention it. Like Richard suggested, insisting that there be evidence for the call on both strands will generally get rid of these, thankfully. (Edit: Maybe that thread wasn't here, as I can't seem to hunt it down. If anyone remember it, link us up!)
      Last edited by Michael.James.Clark; 02-11-2011, 02:57 PM.
      Mendelian Disorder: A blogshare of random useful information for general public consumption. [Blog]
      Breakway: A Program to Identify Structural Variations in Genomic Data [Website] [Forum Post]
      Projects: U87MG whole genome sequence [Website] [Paper]

      Comment

      • csoong
        Member
        • Jun 2009
        • 74

        #18
        Thanks for all the detailed responses!
        Could anyone further explain the difference of an early CCGG vs a late one? At the program level what is happening here?

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by mylaser
          Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
          If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
          This guide explains everything you need to know about...
          Yesterday, 01:13 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-02-2026, 11:08 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Working...